Lindsay Hill-Batorski works on an experimental flu vaccine at Madison-based FluGen. The company is adapting its flu vaccine to work against the new coronavirus.
By inserting gene sequences from the new coronavirus into its experimental influenza vaccine, Madison-based FluGen hopes to develop a vaccine for COVID-19 that also might protect against flu.
FluGen scientists, including Mike Moser, are working around the clock in shifts. That helps them maintain physical distancing while working on two experimental vaccines, one for flu and another against the new coronavirus, which also might protect against flu.
A microscope image shows how cells are affected by a vaccine at FluGen, a Madison company trying to develop vaccines against the flu and the new coronavirus.
Lindsay Hill-Batorski sets up a test to check the effect of a flu vaccine at FluGen. The company's CoroFlu vaccine candidate against the new coronavirus is one of roughly 100 or more contenders to become an approved immunization against COVID-19.
Lindsay Hill-Batorski works on an experimental flu vaccine at Madison-based FluGen. The company is adapting its flu vaccine to work against the new coronavirus.
FluGen scientists, including Mike Moser, are working around the clock in shifts. That helps them maintain physical distancing while working on two experimental vaccines, one for flu and another against the new coronavirus, which also might protect against flu.
A microscope image shows how cells are affected by a vaccine at FluGen, a Madison company trying to develop vaccines against the flu and the new coronavirus.
Lindsay Hill-Batorski sets up a test to check the effect of a flu vaccine at FluGen. The company's CoroFlu vaccine candidate against the new coronavirus is one of roughly 100 or more contenders to become an approved immunization against COVID-19.
